The global axial spondyloarthritis drug market is anticipated to grow at a significant CAGR of 4.1% during the forecast period. Increasing Chronic inflammatory back pain, combined with the stiffness of the pelvis and lower back among people, is the most common symptom of axial spondyloarthritis, which is driving the growth of the market. For instance, according to the information provided by American Chiropractic Association in 2022, 80% of the American population will suffer from lower back pain. Additionally, the availability of treatment options such as physiotherapy is expanding the growth of the market. However, a key factor impeding growth is the limited therapeutic choices associated with axial spondyloarthritis along with the high treatment costs and a lack of awareness in rural areas.
Get Free Sample link @ https://www.omrglobal.com/request-sample/axial-spondyloarthritis-drug-market
The global axial spondyloarthritis drug market is hardly hit by the COVID-19 Pandemic since December 2019. The COVID-19 pandemic in the major economies had disrupted manufacturing and transportation across the globe. The COVID-19 pandemic had affected health care, however in order to discover more effective drugs strategic initiative has been done by various key market players which are providing effective recovery to the market.
A full report of Global Axial Spondyloarthritis Drug Market available @ https://www.omrglobal.com/industry-reports/axial-spondyloarthritis-drug-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Axial Spondyloarthritis Drug Market by Type
- Certolizumab Pegol
- Etanercept Biosimilar
- Ixekizumab
- Others (Secukinumab)
- Global Axial Spondyloarthritis Drug Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Abbott
- AbbVie Inc.
- Amgen Inc.
- GlaxoSmithKLine Plc.
- Kyowa Kirin Co., Ltd.
- Merck & Co. Inc.
- Pfizer Inc.
- Sandoz International GmbH
- KYOCERA Corp.
- Sun Pharmaceutical Industries Ltd.
- UCB S.A.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global axial spondyloarthritis drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/axial-spondyloarthritis-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
